loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

180 Reports in Biotechnology

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Analyst - Marianna Tcherpakov| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

The Chinese Market for DNA Sequencing

Published - Jun 2018 | Analyst - Jason Chen| Code - BIO152B

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Biosimilars: Global Markets

Published - Apr 2018 | Analyst - Kamna Jhamb| Code - BIO090C

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Artificial Blood: Global Markets to 2027

Published - Apr 2018 | Analyst - BCC Research Staff| Code - BIO164A

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Cell Therapy Processing: Global Markets and Technologies

Published - Apr 2018 | Analyst - Sangeeta Rai| Code - BIO160A

The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.

The Global Market for Stem Cells

Published - Apr 2018 | Analyst - Paul Evers| Code - BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

Biologics Development and Manufacturing Testing: Technologies and...

Published - Mar 2018 | Analyst - David Peters| Code - BIO155A

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Mobile Apps for DNA Sequencing: Global Markets

Published - Mar 2018 | Analyst - Smruti Munshi| Code - BIO156A

The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.

Drug Discovery Technologies

Published - Feb 2018 | Analyst - Shalini Shahani Dewan| Code - BIO020F

The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.

Global Markets for Research Antibodies

Published - Jan 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO141B

The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.

Single-cell Omics: Emerging Technologies and Markets

Published - Jan 2018 | Analyst - John Bergin| Code - BIO143B

The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.

Cancer Stem Cells: Technologies and Global Markets

Published - Jan 2018 | Analyst - Sangeeta Rai| Code - BIO158A

The global market for cancer stem cells will grow from $745 million in 2017 to $1.9 billion by 2022 with a compound annual growth rate (CAGR) of 21.2% for the period of 2017-2022.

Global Markets for Enzyme Inhibitors

Published - Jan 2018 | Analyst - Shalini Shahani Dewan| Code - BIO057C

The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.

Botanical and Plant-derived Drugs: Global Markets

Published - Dec 2017 | Analyst - Kim Lawson| Code - BIO022H

The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.

Commercial Amino Acids

Published - Nov 2017 | Analyst - Jon Evans| Code - BIO007L

The U.S. amino acid market was valued at around $1.9 billion in 2016. This market will grow from nearly $2.0 billion in 2017 to $2.5 billion by 2022 with a compound annual growth rate (CAGR) of 4.8% for the period of 2017-2022.

Antibody Drugs: Technologies and Global Markets

Published - Oct 2017 | Analyst - Shalini Shahani Dewan| Code - BIO016K

The global market for antibody drugs reached $80.8 billion in 2016. The market should reach $114.6 billion by 2022 increasing from $84.5 billion in 2017, at a compound annual growth rate (CAGR) of 6.3% from 2017 through 2022. 

Liquid Biopsy Research Tools, Services and Diagnostics: Global Ma...

Published - Oct 2017 | Analyst - John Bergin| Code - BIO150B

The global liquid biopsy market should reach $4.5 billion by 2022 from $1.5 billion in 2017 at a compound annual growth rate (CAGR) of 24.2%, from 2017 to 2022.

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Mar...

Published - Oct 2017 | Analyst - Shalini Shahani Dewan| Code - BIO115C

The global market for microRNA tools reached $756.5 million and $829.8 million in 2015 and 2016, respectively. This market is estimated to reach nearly $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.5% for 2016-2021. 

Molecular Diagnostics: Technologies and Global Markets

Published - Oct 2017 | Analyst - Jon Evans| Code - BIO063D

The global molecular diagnostics market was valued at nearly $10.6 billion in 2016. The market is projected to grow at a compound annual growth rate (CAGR) of 14.3% from 2017 through 2022 to reach $12.2 billion by 2017 and $23.8 billion by 2022.

Cell-based Assays: Technologies and Global Markets

Published - Jul 2017 | Analyst - Usha Nagavarapu| Code - BIO080C

The global market for cell-based assays reached $15.2 billion in 2015. This market is expected to increase from $17.1 billion in 2016 to nearly $28.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.6% for 2016-2021.

Induced Pluripotent Stem Cells: Global Markets

Published - Jun 2017 | Analyst - Mike (Ke Ke) Fan| Code - BIO135B

The global market for induced pluripotent stem cells (iPSCs) reached $2.1 billion in 2016. The market should reach $3.6 billion in 2021, increasing at a compound annual growth rate (CAGR) of 11.6% from 2016 through 2021.

Next-generation Sequencing: Emerging Clinical Applications and Gl...

Published - Jun 2017 | Analyst - John Bergin| Code - BIO126C

The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Jun 2017 | Analyst - Shalini Shahani Dewan| Code - BIO014J

The global market for media, sera and reagents used in cell culture will grow from nearly $3.6 billion in 2016 to $4.6 billion by 2021 at a compound annual growth rate (CAGR) of 5.5% between 2016 and 2021.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Jun 2017 | Analyst - Shalini Shahani Dewan| Code - BIO099C

The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.

3D Cell Cultures: Technologies and Global Markets

Published - May 2017 | Analyst - Robert Hunter| Code - BIO140B

The three-dimensional cell culture market reached $1.0 billion in 2016 and should reach $3.9 billion in 2021, with a compound annual growth rate (CAGR) of 32.7% from 2016 to 2021.

22 Upcoming Reports in Biotechnology

Digital Polymerase Chain Reaction (PCR) Technology: Global Markets

Target Date - May 2018| Author - Todd Graham| Code - BIO137B| Price - $3,950

This report provides: 

  • An overview of the global market for digital polymerase chain reaction (PCR) technology.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of key manufacturers, suppliers, users, and a variety of factors influencing demand.
  • Patent analyses.
  • Comprehensive company profiles of major players in the market.

Notify Me

Synthetic Biology: Global Markets

Target Date - Jun 2018| Author - John Bergin| Code - BIO066E| Price - $5,500

This report provides: 

  • An overview of the global markets for synthetic biology.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells.
  • Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics.
  • Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture. 
  • Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape.
  • Assessments of the products and technologies most commercially viable now and in the near future. 
  • Company profiles of major players in the market.

Notify Me

Cardiac Biomarkers: Technologies and Global Markets

Target Date - Jun 2018| Author - Paul Taylor| Code - BIO128C| Price - $5,500

This report provides: 

  • An overview of the global market for cardiac biomarkers and related technologies.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Classification of cardiac biomarkers by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease.
  • Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT).
  • Examination of the technology regarding diagnostic methods, instrumentation, newly issued patents, and new patent applications.
  • Coverage of clinical guidelines and government regulations.
  • Company profiles of major players in the market.

Notify Me

Immunohistochemistry (IHC): Global Markets to 2022

Target Date - Jun 2018| Author - Vijay Laxmi| Code - BIO161A| Price - $5,500

This report provides: 

  • An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Coverage of major trends and challenges that affect the market and the supplier landscape.
  • End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes.
  • Evaluation of the market's dynamics, including growth drivers and restraints.
  • Company profiles of major players in the market.

Notify Me

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Target Date - Jul 2018| Author - Todd Graham| Code - BIO157A| Price - $4,950

This report provides: 

  • An overview of the global market for polymerase chain reaction (PCR) in point-of-care (POC) diagnostics.
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Detailed analysis of point-of-care molecular diagnostics, technological trends, and governmental regulatory policies.
  • Examination of various segments of the POC-PCR market, including cyclers, systems, applications, and cartridges.
  • Patent analyses.
  • Company profiles of major players in the market.

Notify Me

Global Market for Neurology Products

Target Date - Jul 2018| Author - Joanne Maddox| Code - BIO078A| Price - $5,500

This report provides: 

  • An overview of the global market for the neurology products.
  • Analyses of global market trends, with data from 2016, estimates for 2017, projections of compound annual growth rates (CAGRs) through 2022.
  • An in-depth analysis of new products in the development pipeline, as well as newly-emerging drug-device combinations and stem cell therapies.
  • A look in to the manufacturers of urological technologies based on product types, market share, region, and key corporate activities.
  • Analysis of the market in terms of the regulatory and reimbursement environment and factors influencing market growth and demand
  • Comprehensive company profiles of major players in the industry.

Notify Me

Biological Therapies for Cancer: Technologies and Global Markets

Target Date - Jul 2018| Author - Usha Nagavarapu| Code - BIO048D| Price - $4,950

This report provides:

  • An overview of the global market and technologies for biological therapies for cancer.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Detailed analyses of products in the market, market structure and competitive environments, cancer markets in newly emerging therapeutics, and analysis of biosimilars and their impact on the market.
  • Details concerning the strengths, weaknesses, opportunities, and threats facing various cancer biotherapeutics already on the market.
  • A look at major issues involved in the research and development (R&D) of more effective cancer therapeutics, and new cancer therapeutics in development and in clinical trials.
  • Profiles of major players in the cancer biotherapeutics field.

Notify Me

Biologic Therapeutic Drugs: Technologies and Global Markets

Target Date - Jul 2018| Author - Geeta Ogra Bedi| Code - BIO079D| Price - $4,950

This report provides:

  • An overview of the global market for biologic therapeutic drugs.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Coverage of large market segments, such as monoclonal antibodies (mAb), therapeutic proteins, and vaccines.
  • Examination of the competitive environment, with a special focus on how new products and technologies are influencing the current standards of care.
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of current market leaders, as well as companies with innovative products  poised to advance within the forecast period.

Notify Me

Companion Diagnostics: Technologies and Markets

Target Date - Jul 2018| Author - Marianna Tcherpakov| Code - BIO077D| Price - $5,500

This report provides: 

  • An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
  • Analyses of market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023.
  • Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
  • Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
  • Profiles of major players as well as a list of current companies that have new companion diagnostics products in development.

Notify Me

Proteomics: Technologies and Global Markets

Target Date - Jul 2018| Author - Bhavna Joshi| Code - BIO034E| Price - $5,500

This report provides market size estimates and forecasts for the global market and all major market segments through 2023.

Notify Me

Cancer Profiling and Pathways: Technologies and Global Markets

Target Date - Jul 2018| Author - Usha Nagavarapu| Code - BIO073C| Price - $4,950

This report provides:

  • An overview of the global market for cancer profiling and pathways.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of products in this market, newly emerging tools, diagnostics and therapeutics, and their impacts on the market.
  • Examination of evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering molecular mechanisms  involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers.
  • Identifications of important cancer profiling techniques, market shares by types of products on the market, and market shares by company, as well as types of cancers and biomarkers.
  • Coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials and currently marketed, and clinical-stage development products.
  • Company profiles of key players in the market.

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM